Article
A Hybrid Drug Limits Resistance by Evading the Action of the Multiple Antibiotic Resistance Pathway.
Molecular biology and evolution - 1 Feb 2016
Wang Kathy K, Stone Laura K, Lieberman Tami D, Shavit Michal, Baasov Timor, Kishony Roy
Abstract excerpt
Hybrid drugs are a promising strategy to address the growing problem of drug resistance, but the mechanism by which they modulate the evolution of resistance is poorly understood. Integrating high-throughput resistance measurements and genomic sequencing, we compared Escherichia coli populations evolved in a hybrid antibiotic that links ciprofloxacin and neomycin B with populations evolved in combinations of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
